Trial Profile
Atorvastatin Effectiveness And Safety In Cardiology Patients In Real World Setting: A Registry Study In China
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Coronary disorders; Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms ATTENTION
- Sponsors Pfizer
- 12 Sep 2018 Status changed from active, no longer recruiting to completed.
- 09 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 28 Jun 2018 Planned End Date changed from 23 Oct 2018 to 1 Aug 2018.